Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 2:47 PM

Amyotrophic Lateral Sclerosis

Type: Keyphrase
Name: Amyotrophic Lateral Sclerosis
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Vocal Cord Dysfunction in Amyotrophic Lateral Sclerosis: Four Cases and a Review of the Literature
Archives of Neurology ... [MDLinx - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents
Smoking Ups Risk of Lou Gehrig's Disease
Smoking escalates the risk of developing Amyotrophic Lateral Sclerosis (ALS), which is also called as Lou Gehrig's disease, researchers said.Lead researcher and neurologist Dr. Carmel Armon, from Baystate Medical Centre, has found compelling evidence ... [MedIndia - 11/19/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents (in Biology)
Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis
Today in Demyelinating Disorders...keeping you currentReceive free subspecialty "5-minute updates" via emailJournal of Neuroimmunology, 11/20/09Brain Pathology, 11/20/09Amyotrophic Lateral Sclerosis, 11/20/09 ... [MDLinx - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
Cyanobacteria and BMAA exposure from desert dust: A possible link to sporadic ALS among Gulf War veterans
Amyotrophic Lateral Sclerosis ... [MDLinx - 11/20/2009]
First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents
A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms
Amyotrophic Lateral Sclerosis ... [MDLinx - 11/20/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Biology)
French drugmaker tests drug for Lou Gehrig's disease
Trophos is conducting midstage trials to test the effectiveness of olesoxime in patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. The drug appears to keep motor neurons from dying by inhibiting formation of the mitochondrial permeability ... [SmartBrief - 11/17/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents
ALS claims major league scout
The ring, still in its box, sits on a small table in the living room of the Hanover home of John Neiderer Sr.Neiderer picked up the box and said, "Here's something that maybe you haven't seen."The diamond-studded ring, complete with the Neiderer name, ... [Individual.com - 11/18/2009]
First Reported 11/11/2009 - Updated 11/12/2009 - 3 Documents (in Internet & IT)
EyeWriter: Physically Paralyzed Artist Draws Graffiti (on Buildings)
The truly amazing EyeWriter [eyewriter.org] project is part of an ongoing to empower people who are suffering from ALS (short for Amyotrophic Lateral Sclerosis) with creative computational technologies.Members of Free Art and Technology (FAT), OpenFrameworks, ... [TechNews.AM - 11/12/2009]
First Reported 11/12/2009 - Updated 11/12/2009 - 2 Documents
Cytokinetics' Market Potential
In the news: Cytokinetics (CYTK) has initiated phase I clinical trial to investigate the pharmacokinetic profile of CK-2017357. Cytokinetics has also initiated the second part, or "Part B", of a previously initiated, Phase I clinical trial of CK-2017357 ... [Healthcare Sector and Stocks Analysis from Seek ... - 11/12/2009]
First Reported 11/13/2009 - Updated 11/13/2009 - 1 Documents (in Biology)
Amyotrophic Lateral Sclerosis
(ALS)Locate A DoctorSpecialityCity (or)PincodeAmyotrophic Lateral Sclerosis (ALS)Font SizeRSS CommentsAboutOther names - C Maladie de Charcot, Lou Gehrig's diseaseAmyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal disease that is ... [MedIndia - 11/13/2009]
First Reported 11/13/2009 - Updated 11/13/2009 - 1 Documents (in Internet & IT)
The Eyewriter
The folks at Graffiti Research Lab, openFrameworks, The Fat Lab and The Ebeling Group have teamed up to create The EyeWriter, a "low-cost eye-tracking apparatus + custom software that allows graffiti writers and artists with paralysis resulting ... [Boing Boing - 11/13/2009]
First Reported 10/22/2009 - Updated 10/22/2009 - 1 Documents
Walk for Gehrig's Disease is Saturday
Organizers are hoping at least 700 people will walk in this Saturday's 11th annual Tucson fundraising walk for ALS -- amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease.The annual Walk to Defeat ALS event is scheduled for 9 a.m. at Reid ... [Individual.com - 10/22/2009]

Quotes

The folks at Graffiti Research Lab , openFrameworks , The Fat Lab and The Ebeling Group have teamed up to create The EyeWriter , a "low-cost eye-tracking apparatus + custom software that allows graffiti writers and artists with paralysis resulting from Amyotrophic lateral sclerosis to draw using only their eyes." Instructables has a post up . I'd love to witness this in action, up close, with someone who really needs to use it...
The Eyewriter [Boing Boing - 11/13/2009]
...TalkLeft is not responsible for and often disagrees with material posted in the comments section. Read at your own risk. Stats "The pump don't work 'cause the vandals took the handles" 8 comments (8 topical) Readers Must or to Comment by on Wed Nov 04, 2009 at 10:22:59 AM EST
Maine Votes to Legalize Medical Marijuana Dispensaries [Talkleft - 11/05/2009]
In the report, the analyst notes: "AVNR in mid-October announced detailed results from the confirmatory double-blind phase IIIIII STAR trial evaluating two doses of the investigational drug Zenvia(TM) (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study, Zenvia 30/10 mg and 20/10 mg met the primary efficacy endpoint by reducing PBA episode rates. 'The fundamental outlook for the pharmaceuticals sub-industry for the next 12 months is neutral. Several analysts forecast a modest sales decline in 2009, with volume restricted by less favorable foreign exchange, generic erosion in patent-expired drugs, slow new product flow, and weakness in the overall economy. Many also think the sector faces tougher political and regulatory environments, including proposed drug price discounting in both the Medicare and Medicaid programs. However, sector EPS should show low single digit growth helped by cost restructurings and common shareshare buybacks.' To read the entire report visit: http://www.investorsoup.com/lp/AVNR"
Trading Outlook for Avanir Pharmaceuticals Inc. Issued by [GlobeNewswire via MSN Money - 11/03/2009]

More Content

All (235) | News (187) | Reports (0) | Blogs (28) | Audio/Video (0) | Fact Sheets (0)
sort by: Date | Relevance
Schizophrenia Gene's Role May Be Broader, More ... [MediLexicon - 1 hour ago]
A cluster of amyotrophic lateral sclerosis in N... [MDLinx - 11/20/2009]
Cyanobacteria and BMAA exposure from desert dus... [MDLinx - 11/20/2009]
Deep gray matter T2 hypointensity is present in... [MDLinx - 11/20/2009]
American-Israeli company closes in on ALS treat... [Haaretz - 11/20/2009]
Smoking Ups Risk of Lou Gehrig's Disease [MedIndia - 11/19/2009]
Weill Cornell science briefs: November 2009 [EurekAlert! - 11/19/2009]
Vocal Cord Dysfunction in Amyotrophic Lateral S... [MDLinx - 11/19/2009]
Display raises awareness about ALS [Miami Herald - 11/19/2009]
Focusing on Key Indications, Securing Partnersh... [GenomeWeb - 11/18/2009]
ALS claims major league scout [Individual.com - 11/18/2009]
French drugmaker tests drug for Lou Gehrig's di... [SmartBrief - 11/17/2009]
Neuralstem provides financial and business upda... [News-Medical.Net - 11/17/2009]
Neuralstem, Inc. Reports Third Quarter Financia... [Business Wire via MSN Money - 11/17/2009]
Neuralstem, Inc. Reports Third Quarter Financia... [RBC Dain Rauscher - 11/17/2009]
Neuralstem, Inc. Reports Third Quarter Financia... [Business Wire UK - 11/17/2009]
Neuralstem, Inc. Reports Third Quarter Financia... [Business Wire UK - 11/17/2009]
Study establishes link between smoking and deve... [News-Medical.Net - 11/17/2009]
New Hope for Neuron Protection [Technology Review - 11/17/2009]
Smoking may now be considered an established ri... [Genetic Engineering News - 11/16/2009]
Smoking may now be considered an established ri... [EurekAlert! - 11/16/2009]
Research and Markets: Dealmaking and Industry O... [Forbes.com - 11/16/2009]
H1N1 flu virus update (09/11/13) [CNB Online - 11/15/2009]
Amyotrophic Lateral Sclerosis [MedIndia - 11/13/2009]
RXi’s CEO Resigns as Company Looks to Clinic, I... [GenomeWeb - 11/12/2009]
Cytokinetics' Market Potential [Seeking Alpha - 11/12/2009]
EyeWriter: Physically Paralyzed Artist Draws Gr... [TechNews.AM - 11/12/2009]
ALS Treatment Awarded Orphan Drug Designation [PharmaceuticalProcessing - 11/11/2009]
Blame Ottawa for flu shot uncertainty: N.L. min... [CBC - 11/11/2009]
Eyewriter: physically paralyzed artist draws gr... [TechNews.AM - 11/11/2009]
1 2 3 4 5 6 7
In Focus
  •  
Lou Gehrig, Stephen Hawking, Michael Goldsmith, [more]
  •  
NeuralStem, Cytokinetics Inc, AVANIR Pharmaceuticals, [more]
  •  
American Academy of Neurology, Food and Drug Administration, ALS Association, [more]
  •  
Neuron, Basic Research, spinal cord, [more]
  •  
San Francisco (United States), Cleveland (Ohio, United States), San Diego (California, United States), [more]
  •  
Netherlands, United States, Canada, [more]
  •  
Medicine, Biology, Internet & IT, [more]
  •  
Pharma & Biotech, Health, IT, [more]
NEJM — Collection Updates for Neuro ..., NEJM — Collection Updates for Genetics, News-Medical.Net, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
The Eyewriter [Boing Boing - 11/13/2009]
The folks at Graffiti Research Lab, openFrameworks, The Fat Lab and The Ebeling Group have teamed up to create The EyeWriter, a "low-cost eye-tracking apparatus ...
Cytokinetics' Market Potential [Healthcare Sector and Stocks Analysis from Seek ... - 11/12/2009]
In the news: Cytokinetics (CYTK) has initiated phase I clinical trial to investigate the pharmacokinetic profile of CK-2017357. Cytokinetics has also initiated the ...
Cytokinetics' Market Potential [Biotech Sector and Stocks Analysis from Seeking ... - 11/12/2009]
In the news: Cytokinetics (CYTK) has initiated phase I clinical trial to investigate the pharmacokinetic profile of CK-2017357. Cytokinetics has also initiated the ...
EyeWriter: Physically Paralyzed Artist Draws Gr... [information aesthetics - 11/11/2009]
The truly amazing EyeWriter [eyewriter.org] project is part of an ongoing collaborative research effort to empower people who are suffering from ALS (short for ...
Maine Votes to Legalize Medical Marijuana Dispe... [Talkleft - 11/05/2009]
Maine is now the third state to legalize dispensaries. In a landmark vote, Maine voters today approved Question 5, making the state the third in the country to ...
1 2 3 4 5 6

  •  
  •  
  •